サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1574677

コンピテントセルの世界市場レポート 2024年

Competent Cells Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
コンピテントセルの世界市場レポート 2024年
出版日: 2024年10月22日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

コンピテントセル市場規模は、今後数年で急成長が見込まれます。2028年には年間平均成長率（CAGR）13.4％で43億9,000万米ドルに成長します。予測期間中に予想される成長は、個別化医療に対する需要の高まり、バイオテクノロジー新興企業への投資の増加、組換えタンパク質生産に対するニーズの高まり、慢性疾患の有病率の増加、産業バイオテクノロジーソリューションに対する需要の急増など、いくつかの要因に起因しています。この成長に影響を与えると予想される主な動向には、技術の進歩、人工知能の統合、量子コンピューティングの発展、5G技術の採用、ウェアラブル技術の革新などがあります。

バイオ医薬品産業の拡大がコンピテントセル市場の成長を牽引すると予想されます。この業界は、バイオテクノロジーと分子生物学を活用して高度な治療法や治療を生み出す、生物由来の医薬品の開発、生産、商業化に重点を置いています。バイオ医薬品セクターは、バイオテクノロジーの急速な進歩、個別化医療に対する需要の増加、革新的治療のための研究開発投資の増加により成長しています。この分野では、遺伝子工学、遺伝子クローニング、タンパク質発現のためのコンピテントセルが極めて重要であり、医薬品開発に必要な組み換えタンパク質、治療用酵素、その他の生物製剤の生産を促進しています。例えば、英国の政府機関である保健社会福祉省は2024年5月、中核的なバイオ医薬品セクターは2021/22年に467億ポンド（593億2,000万米ドル）の収益を上げ、ライフサイエンス産業全体の43％を占めると報告しました。さらに、オーストラリアを拠点とする団体AusBiotechは、バイオテクノロジー部門の売上高が2024年までに56億6,000万米ドル（86億7,000万豪ドル）に達し、4.4％の成長率を反映すると予測しています。その結果、バイオ医薬品産業の拡大がコンピテントセル市場の成長を促進しています。

コンピテントセル市場の主要企業は、細胞・遺伝子治療を改善し、遺伝子形質転換プロセスの効率を高めるために、複製コンピテント・レンティウイルスキットなどの革新的なキットを導入しています。細胞療法や遺伝子療法は、病気の治療や治癒のために細胞や遺伝子を改変したり利用したりするものです。例えば、米国の臨床診断メーカーであるバイオ・ラッド・ラボラトリーズ社は、2024年2月にVericheck ddPCR replication competent lentivirus kitとVericheck ddPCR replication competent AAV kitをリリースしました。これらのキットは、高度な液滴デジタルPCR（ddPCR）技術を利用して、複製コンピテント・レンティウイルス（RCL）およびアデノ随伴ウイルス（AAV）を高感度かつ高精度に検出・定量します。この技術は、潜在的に有害な複製コンピテントウイルスを検出・除去することにより、治療用途に使用されるウイルスベクターの安全性と有効性を確保するために不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界のコンピテントセル市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のコンピテントセル市場の実績：規模と成長, 2018-2023
  • 世界のコンピテントセル市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界のコンピテントセル市場：タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 化学的コンピテントセル
  • エレクトロコンピテントセル
  • 超有能細胞
  • 世界のコンピテントセル市場：用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • クローン
  • タンパク質発現
  • 突然変異誘発
  • その他の用途
  • 世界のコンピテントセル市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 契約調査機関
  • 製薬およびバイオテクノロジー企業
  • 学術調査機関
  • その他のエンドユーザー

第7章 地域別・国別分析

  • 世界のコンピテントセル市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界のコンピテントセル市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • コンピテントセル市場：競合情勢
  • コンピテントセル市場：企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Avantor Inc.
    • Agilent Technologies Inc.
    • Sigma-Aldrich
    • Bio-Rad Laboratories Inc.

第31章 その他の大手企業と革新的企業

  • QIAGEN N.V.
  • Promega Corporation
  • GenScript Biotech Corporation
  • Takara Bio Inc.
  • New England Biolabs Inc.
  • TransGen Biotech Co. Ltd.
  • HiMedia Laboratories Pvt. Ltd.
  • Zymo Research Corporation
  • Lucigen Corporation
  • Meridian Bioscience Inc.
  • Codex DNA Inc.
  • OriGene Technologies Inc.
  • SERVA Electrophoresis GmbH
  • SMOBIO Technology Inc.
  • Yeastern Biotech Co. Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r19838

Competent cells are bacterial cells that have been treated to become capable of taking up foreign deoxyribonucleic acid (DNA). These cells are crucial in molecular biology for cloning and transformation experiments, as they facilitate the introduction of genetic material into the cells. The main goal of using competent cells is to enable the uptake of foreign DNA during the transformation process.

The primary types of competent cells are chemically competent cells, electrocompetent cells, and ultracompetent cells. Chemically competent cells are prepared through chemical treatments that increase their membrane permeability, allowing DNA to enter more easily. These cells are utilized in various applications such as cloning, protein expression, and mutagenesis. They are employed by a range of end users including contract research organizations, pharmaceutical and biotechnology companies, and academic research institutions.

The competent cells market research report is one of a series of new reports from The Business Research Company that provides competent cells market statistics, including competent cells industry global market size, regional shares, competitors with a competent cells market share, detailed competent cells market segments, market trends and opportunities, and any further data you may need to thrive in the competent cells industry. This competent cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The competent cells market size has grown rapidly in recent years. It will grow from $2.34 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 13.3%. The growth during the historic period can be attributed to several factors, including a rising demand for genetic cloning, increased government funding for life sciences research, expansion of the biotechnology workforce, a growing focus on rare disease research, and a rise in the outsourcing of research activities to contract research organizations.

The competent cells market size is expected to see rapid growth in the next few years. It will grow to $4.39 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The anticipated growth during the forecast period can be attributed to several factors, including the rising demand for personalized medicine, increased investment in biotechnology startups, growing need for recombinant protein production, a higher prevalence of chronic diseases, and a surge in demand for industrial biotechnology solutions. Key trends expected to influence this growth include advancements in technology, the integration of artificial intelligence, developments in quantum computing, the adoption of 5G technology, and innovations in wearable technology.

The expansion of the biopharmaceutical industry is anticipated to drive the growth of the competent cells market. This industry focuses on the development, production, and commercialization of drugs derived from biological sources, utilizing biotechnology and molecular biology to create advanced therapies and treatments. The biopharmaceutical sector is growing due to rapid advancements in biotechnology, increased demand for personalized medicine, and rising investments in research and development for innovative treatments. Competent cells are crucial in this field for genetic engineering, gene cloning, and protein expression, facilitating the production of recombinant proteins, therapeutic enzymes, and other biologics necessary for drug development. For example, the Department of Health and Social Care, a UK-based government department, reported in May 2024 that the core biopharmaceutical sector generated £46.7 billion ($59.32 billion) in revenue during 2021/22, representing 43% of the total life sciences industry. Additionally, AusBiotech, an Australia-based organization, projected that the biotechnology sector would reach USD 5.66 billion (AU$ 8.67 billion) in revenue by 2024, reflecting a 4.4% growth rate. Consequently, the expanding biopharmaceutical industry is fueling the growth of the competent cells market.

Key companies in the competent cells market are introducing innovative kits, such as replication competent lentivirus kits, to improve cell and gene therapies and enhance the efficiency of genetic transformation processes. Cell and gene therapies involve modifying or using cells or genes to treat or cure diseases. For instance, Bio-Rad Laboratories Inc., a US-based clinical diagnostics manufacturer, released the Vericheck ddPCR replication competent lentivirus kit and the Vericheck ddPCR replication competent AAV kit in February 2024. These kits utilize advanced droplet digital PCR (ddPCR) technology to detect and quantify replication-competent lentivirus (RCL) and adeno-associated virus (AAV) with high sensitivity and precision. This technology is vital for ensuring the safety and effectiveness of viral vectors used in therapeutic applications by detecting and eliminating potentially harmful replication-competent viruses.

In June 2021, Hillhouse Capital Management Ltd., a private equity firm based in Hong Kong, acquired a 2.99% stake in Genscript Biotech Corporation from GenScript Corporation for HKD 1.2 billion ($0.15 billion). This acquisition aims to enhance Hillhouse Capital Management's biotechnology portfolio by leveraging Genscript Biotech Corporation's expertise in molecular biology and genetic engineering, thus fostering growth and innovation in advanced biotech solutions and services. Genscript Biotech Corporation, a US-based life sciences company, offers a range of products and services, including competent cells for molecular biology research and applications.

Major companies operating in the competent cells market are Thermo Fisher Scientific Inc., Avantor Inc., Agilent Technologies Inc., Sigma-Aldrich, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, GenScript Biotech Corporation, Takara Bio Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., HiMedia Laboratories Pvt. Ltd., Zymo Research Corporation, Lucigen Corporation, Meridian Bioscience Inc., Codex DNA Inc., OriGene Technologies Inc., SERVA Electrophoresis GmbH, SMOBIO Technology Inc., Yeastern Biotech Co. Ltd., Scarab Genomics LLC, Enzynomics Co. Ltd., NZYTech Lda., Gold Biotechnology Inc., Abyntek Biopharma S.L

North America was the largest region in the competent cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the competent cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the competent cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The competent cells market consists of sales of specialized competent cells, transformation kits, ready-to-use competent cells kits, and competent strain-specific cells. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Competent Cells Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on competent cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for competent cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The competent cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Chemically Competent Cells; Electrocompetent Cells; Ultracompetent Cells
  • 2) By Application: Cloning; Protein Expression; Mutagenesis; Other Applications
  • 3) By End User: Contract Research Organizations; Pharmaceutical And Biotechnology Companies; Academic Research Institutes; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Avantor Inc.; Agilent Technologies Inc.; Sigma-Aldrich; Bio-Rad Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Competent Cells Market Characteristics

3. Competent Cells Market Trends And Strategies

4. Competent Cells Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Competent Cells Market Size and Growth

  • 5.1. Global Competent Cells Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Competent Cells Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Competent Cells Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Competent Cells Market Segmentation

  • 6.1. Global Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chemically Competent Cells
  • Electrocompetent Cells
  • Ultracompetent Cells
  • 6.2. Global Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cloning
  • Protein Expression
  • Mutagenesis
  • Other Applications
  • 6.3. Global Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Contract Research Organizations
  • Pharmaceutical And Biotechnology Companies
  • Academic Research Institutes
  • Other End-Users

7. Competent Cells Market Regional And Country Analysis

  • 7.1. Global Competent Cells Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Competent Cells Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Competent Cells Market

  • 8.1. Asia-Pacific Competent Cells Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Competent Cells Market

  • 9.1. China Competent Cells Market Overview
  • 9.2. China Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Competent Cells Market

  • 10.1. India Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Competent Cells Market

  • 11.1. Japan Competent Cells Market Overview
  • 11.2. Japan Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Competent Cells Market

  • 12.1. Australia Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Competent Cells Market

  • 13.1. Indonesia Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Competent Cells Market

  • 14.1. South Korea Competent Cells Market Overview
  • 14.2. South Korea Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Competent Cells Market

  • 15.1. Western Europe Competent Cells Market Overview
  • 15.2. Western Europe Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Competent Cells Market

  • 16.1. UK Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Competent Cells Market

  • 17.1. Germany Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Competent Cells Market

  • 18.1. France Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Competent Cells Market

  • 19.1. Italy Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Competent Cells Market

  • 20.1. Spain Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Competent Cells Market

  • 21.1. Eastern Europe Competent Cells Market Overview
  • 21.2. Eastern Europe Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Competent Cells Market

  • 22.1. Russia Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Competent Cells Market

  • 23.1. North America Competent Cells Market Overview
  • 23.2. North America Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Competent Cells Market

  • 24.1. USA Competent Cells Market Overview
  • 24.2. USA Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Competent Cells Market

  • 25.1. Canada Competent Cells Market Overview
  • 25.2. Canada Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Competent Cells Market

  • 26.1. South America Competent Cells Market Overview
  • 26.2. South America Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Competent Cells Market

  • 27.1. Brazil Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Competent Cells Market

  • 28.1. Middle East Competent Cells Market Overview
  • 28.2. Middle East Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Competent Cells Market

  • 29.1. Africa Competent Cells Market Overview
  • 29.2. Africa Competent Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Competent Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Competent Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Competent Cells Market Competitive Landscape And Company Profiles

  • 30.1. Competent Cells Market Competitive Landscape
  • 30.2. Competent Cells Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Avantor Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Agilent Technologies Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sigma-Aldrich
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bio-Rad Laboratories Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Competent Cells Market Other Major And Innovative Companies

  • 31.1. QIAGEN N.V.
  • 31.2. Promega Corporation
  • 31.3. GenScript Biotech Corporation
  • 31.4. Takara Bio Inc.
  • 31.5. New England Biolabs Inc.
  • 31.6. TransGen Biotech Co. Ltd.
  • 31.7. HiMedia Laboratories Pvt. Ltd.
  • 31.8. Zymo Research Corporation
  • 31.9. Lucigen Corporation
  • 31.10. Meridian Bioscience Inc.
  • 31.11. Codex DNA Inc.
  • 31.12. OriGene Technologies Inc.
  • 31.13. SERVA Electrophoresis GmbH
  • 31.14. SMOBIO Technology Inc.
  • 31.15. Yeastern Biotech Co. Ltd.

32. Global Competent Cells Market Competitive Benchmarking

33. Global Competent Cells Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Competent Cells Market

35. Competent Cells Market Future Outlook and Potential Analysis

  • 35.1 Competent Cells Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Competent Cells Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Competent Cells Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer